title: Management of JJ stent-related symptoms.
abstract: Ureteric JJ stents are inserted in numerous pa- tients as a routine procedure. Nevertheless, the ideal JJ stent that does not cause any lower urinary tract symptoms has not been developed yet. Even special validated ques- tionnaires have been used for the assessment of JJ stent-related symtoms. For the management of such symtoms usually alpha-blockers are admin- istered. Also, studies have examined the efficacy and safety of anticholinergics and calcium channel blo- ckers. In this article we review the literature upon the management of JJ stent-related symptoms.
authors.forename: Athanasios
authors.initials: A
authors.lastname: Papatsoris
authors.forename: Athanasios
authors.initials: A
authors.lastname: Dellis
authors.forename: George
authors.initials: G
authors.lastname: Daglas
authors.forename: Francesco
authors.initials: F
authors.lastname: Sanguedolce
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D018680:Cholinergic Antagonists / Q000494:pharmacology*; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000188:drug therapy / Q000209:etiology; D017063:Outcome Assessment, Health Care; D011183:Postoperative Complications / Q000188:drug therapy*; D019919:Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation; D015607:Stents / Q000009:adverse effects*; D014513:Ureter / Q000503:physiopathology / Q000601:surgery
chemical_list: D000317:Adrenergic alpha-Antagonists; D002121:Calcium Channel Blockers; D018680:Cholinergic Antagonists